MOUNTAIN VIEW, Calif., July 20, 2011 /PRNewswire/ -- Concentric Medical, Inc., the global leader in devices for clot retrieval in ischemic stroke patients, today announced the launch of the expanded family of Merci Retrievers® in Japan. With the addition of the V 2.0 Soft and V 3.0 Soft, through recent Ichihen Approval, the entire family of V Series Merci Retrievers® are now approved and reimbursed in Japan. The Merci Retriever® is a catheter-based medical device that stroke centers use to remove blood clots from the brains of patients suffering an ischemic stroke.
Century Medical Inc. of Japan is Concentric Medical's exclusive distribution partner. Together, the two companies have focused on physician training, post-market surveillance and expanded product offerings to support the first-to-market mechanical thrombectomy device for acute ischemic stroke in Japan. These priorities emphasize the companies' commitment to improving stroke patient care in Japan.
Nobuyuki Sakai, M.D., D.M.Sc., Director, Neurosurgery & Stroke Center at Kobe General Hospital said, "Our treatment for stroke has dramatically changed since the approval of the first Merci Retriever in 2010. Our experience with the Merci Retriever has resulted in high revascularization rates and improved patient outcomes. The recent approval of the V 2.0 Soft and the V 3.0 Soft is valuable for us and I believe these devices will contribute to our improved clinical results."
Yuji Matsumaru, M.D., Ph.D., Director, Department of Endovascular Neurosurgery at Toranomon Hospital said, "In Japan, the Merci Retriever is the first and only device for acute endovascular revascularization. Since the reimbursement approval in October 2010 many patients have been treated with this device and the initial results are very promising. Japanese physicians, including myself, welcome the addition of the V 2.0 Soft and V 3.0 Soft to the family of Merci Re